Aditya Birla Sun Life Pharma & Healthcare Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Aditya Birla Sun Life Pharma & Healthcare Fund Growth Fund Overview

Min. investment

SIP ₹100 & Lump. ₹1000

AUM (Fund size)

₹1,074 Cr

Lock In Period

N/A

Expense Ratio

2.27

Exit Load

For redemption/switchout of units on or before 30 days from the date of allotment: 1.00% of applicable NAV. For redemption/switch-out of units after 30 days from the date of allotment: Nil.

Benchmark

BSE Healthcare Total Return

Aditya Birla Sun Life Pharma & Healthcare Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M0.440.354.07
6M18.972.7525.46
1Y14.705.4124.09
3Y20.4615.2091.34

Portfolio Analysis

  • Equity: 97.63%
  • Debt: 2.39%
  • Others
As on: 2026-07-31
View allocation % by

1. Torrent Pharmaceuticals Ltd.9.94%
2. Sun Pharmaceutical Industries Ltd.9.75%
3. Cipla Ltd.4.56%
4. Aurobindo Pharma Ltd.4.29%
5. Ajanta Pharma Ltd.4.17%
6. Sai Life Sciences Ltd.3.89%
7. Mankind Pharma Ltd.3.58%
8. Lupin Ltd.3.51%
9. Abbott India Ltd.3.35%
10. Emcure Pharmaceuticals Ltd.3.24%
11. IPCA Laboratories Ltd.2.47%
12. Gland Pharma Ltd.2.34%
13. Shilpa Medicare Ltd.2.32%
14. Corona Remedies Ltd.2.29%
15. Procter & Gamble Health Ltd.2.16%
16. Divi's Laboratories Ltd.1.95%
17. Alkem Laboratories Ltd.1.88%
18. Pfizer Ltd.1.26%
19. Biocon Ltd.1.26%
20. Piramal Pharma Ltd.1.16%
21. Anthem Biosciences Ltd.1.07%
22. Dr. Reddy's Laboratories Ltd.1.06%
23. Glaxosmithkline Pharmaceuticals Ltd.0.80%
24. Syngene International Ltd.0.68%
25. Jubilant Pharmova Ltd.0.55%

1. Apollo Hospitals Enterprise Ltd.7.08%
2. Fortis Healthcare Ltd.2.98%
3. Dr. Lal Path labs Ltd.2.12%
4. Jupiter Life Line Hospitals Ltd.2.03%
5. Thyrocare Technologies Ltd.1.91%
6. Metropolis Healthcare Ltd.1.59%
7. Vijaya Diagnostic Centre Ltd.0.98%
8. Manipal Health Enterprises Ltd A0.89%
9. Suraksha Diagnostic Ltd.0.79%
10. Max Healthcare Institute Ltd.0.72%

1. Sanofi Consumer Healthcare India Ltd.1.36%
No Data Found
No Data Found

About Fund Aditya Birla Sun Life Pharma & Healthcare Fund Growth

Aditya Birla Sun Life Pharma & Healthcare Fund Growth managed by Aditya Birla Sun Life Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹1,074 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.27. Under the expert guidance of Dhaval Shah ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Dhaval Shah

Mr. Dhaval Shah holds B.Com, CFA, MMS - Finance (Post graduation). He has worked with Morgan Stanley Investment Management, Reliance Capital Asset Management Ltd. and Edelweiss Securities.

Peer Comparison

Fund NameRatingsAUMExpense Ratio
Tata India Pharma & HealthCare Fund Growth21,541 CR2.28
Quant Healthcare Fund Growth0397 CR3.14
Aditya Birla Sun Life Pharma & Healthcare Fund Growth21,073 CR2.27
UTI Healthcare Fund Growth31,370 CR2.22
SBI Healthcare Opportunities Fund Growth35,399 CR2
Fund Name1Y3Y
This FundTata India Pharma & HealthCare Fund Growth7.767166.2988
This FundQuant Healthcare Fund Growth18.049371.8488
This FundAditya Birla Sun Life Pharma & Healthcare Fund Growth14.70474.8081
This FundUTI Healthcare Fund Growth14.780885.3038
This FundSBI Healthcare Opportunities Fund Growth17.932885.4849

Aditya Birla Sun Life Pharma & Healthcare Fund Growth FAQs

Aditya Birla Sun Life Pharma & Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of Aditya Birla Sun Life Pharma & Healthcare Fund Growth is 2.27. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

Aditya Birla Sun Life Pharma & Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : 0.44%
  • 6 Months : 18.97%
  • 1 Year : 14.70%
  • 3 Years : 20.46%
Returns of Aditya Birla Sun Life Pharma & Healthcare Fund Growth are updated daily based on NAV of ₹ 36.43 as on Aug 21,2026. Since inception, the return has been 74.81%.

You can invest in Aditya Birla Sun Life Pharma & Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of Aditya Birla Sun Life Pharma & Healthcare Fund Growth is ₹1,074 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in Aditya Birla Sun Life Pharma & Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.